Dowsett M - Search Results

1

4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.

Coombes RC, Wilkinson JR, Bliss JM, Shah P, Easton DF, Dowsett M. Coombes RC, et al. Among authors: dowsett m. Br J Cancer. 1991 Aug;64(2):247-50. doi: 10.1038/bjc.1991.285. Br J Cancer. 1991. PMID: 1892751 Free PMC article.

2

Immunoreactive calcitonin production by human lung carcinoma cells in culture.

Ellison M, Woodhouse D, Hillyard C, Dowsett M, Coombes RC, Gilby ED, Greenberg PB, Neville AM. Ellison M, et al. Among authors: dowsett m. Br J Cancer. 1975 Sep;32(3):373-9. doi: 10.1038/bjc.1975.237. Br J Cancer. 1975. PMID: 1233082 Free PMC article.

3

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.

Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratton MR. Wooster R, et al. Among authors: dowsett m. Nat Genet. 1992 Oct;2(2):132-4. doi: 10.1038/ng1092-132. Nat Genet. 1992. PMID: 1303262

4

4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer.

Coombes RC, Hughes SW, Dowsett M. Coombes RC, et al. Among authors: dowsett m. Eur J Cancer. 1992;28A(12):1941-5. doi: 10.1016/0959-8049(92)90232-q. Eur J Cancer. 1992. PMID: 1419285 Clinical Trial.

5

Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment.

Lønning PE, Dowsett M, Jones A, Ekse D, Jacobs S, McNeil F, Johannessen DC, Powles TJ. Lønning PE, et al. Among authors: dowsett m. Breast Cancer Res Treat. 1992;23(1-2):57-62. doi: 10.1007/BF01831476. Breast Cancer Res Treat. 1992. PMID: 1446052 Clinical Trial.

6

An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients.

Dowsett M, Mehta A, King N, Smith IE, Powles TJ, Stein RC, Coombes RC. Dowsett M, et al. Eur J Cancer. 1992;28(2-3):415-20. doi: 10.1016/s0959-8049(05)80065-6. Eur J Cancer. 1992. PMID: 1591054 Clinical Trial.

7

Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.

Davies JH, Dowsett M, Jacobs S, Coombes RC, Hedley A, Shearer RJ. Davies JH, et al. Among authors: dowsett m. Br J Cancer. 1992 Jul;66(1):139-42. doi: 10.1038/bjc.1992.231. Br J Cancer. 1992. PMID: 1637664 Free PMC article. Clinical Trial.

8

Treatment of advanced breast cancer with miconazole: a potential inhibitor of peripheral oestrogen synthesis.

Jones AL, Dowsett MJ, Powles TJ, Gallagher CJ, Coombes RC. Jones AL, et al. Among authors: dowsett mj. Eur J Cancer. 1991;27(3):301. doi: 10.1016/0277-5379(91)90530-q. Eur J Cancer. 1991. PMID: 1827318 No abstract available.

9

The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.

Lønning PE, Jacobs S, Jones A, Haynes B, Powles T, Dowsett M. Lønning PE, et al. Among authors: dowsett m. Br J Cancer. 1991 May;63(5):789-93. doi: 10.1038/bjc.1991.175. Br J Cancer. 1991. PMID: 1828173 Free PMC article.

10

Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.

Haynes BP, Jarman M, Dowsett M, Mehta A, Lønning PE, Griggs LJ, Jones A, Powles T, Stein R, Coombes RC. Haynes BP, et al. Among authors: dowsett m. Cancer Chemother Pharmacol. 1991;27(5):367-72. doi: 10.1007/BF00688859. Cancer Chemother Pharmacol. 1991. PMID: 1847846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters